BDTX-4933

N/A

Report date: 2025/04/20 20:00:03
NME

Base Information

Drug NameBDTX-4933
Drug Alias NameBDTX-4933
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase B-raf inhibitorsRAF serine/threonine protein kinase inhibitors
TargetsSerine/threonine-protein kinase B-rafRAF serine/threonine protein kinase
Therapy Area/IndicationsCentral Nervous System Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesBlack Diamond Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesBlack Diamond Therapeutics IncLaboratoires Servier
Inactive CompaniesN/A
Active IndicationsCentral Nervous System Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A